Page last updated: 2024-12-09

8,10-dodecadien-1-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

8,10-dodecadien-1-ol: isomer of coddling moth sex attractant; RN given refers to (E,E)-isomer, which is codlemone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1787910
CHEMBL ID3187120
SCHEMBL ID407873
SCHEMBL ID687473
MeSH IDM0042406

Synonyms (60)

Synonym
trans,trans-8,10-dodecadien-1-ol
trans-8,trans-10-dodecadien-1-ol
(e,e)-8,10-dodecadien-1-ol
trans-8,trans-10-dodecadienol
(8e,10e)-dodeca-8,10-dienol
einecs 251-761-2
pherocon cm
ai3-34872
brn 1907300
codlelure
ent 34872
8,10-dodecadien-1-ol
(8e,10e)-8,10-dodecadien-1-ol
8,10-dodecadien-1-ol, (8e,10e)-
codlemone
8,10-dodecadien-1-ol, (e,e)-
ccris 9118
e,e-8,10-dodecadien-1-ol
dodecan-8e,10e-dien-1-ol
LMFA05000046
8e,10e-dodecadien-1-ol
NCGC00164289-01
(8e,10e)-dodeca-8,10-dien-1-ol
NCGC00164289-02
tox21_300836
cas-33956-49-9
dtxsid1035288 ,
dtxcid9015288
NCGC00254740-01
AKOS024319620
77n0yto8ym ,
33956-49-9
unii-77n0yto8ym
8,10-dodecadien-1-ol,(8e,10e)-
SCHEMBL407873
SCHEMBL687473
e,e-8,10-dodecadienol
checkmate technical pheromone
dodecadien-1-ol, (e,e)-8,10-
cp-mk
feroflon sr-2
CHEMBL3187120
trans-8, trans-10-dodecadienol
mfcd00009992
codlemone, pestanal(r), analytical standard
J-019394
e8e10-12 oh
E76117
(e,e)-8,10-dddol
Q2278916
(8e,10e)-dodecadien-1-ol
trans-8, trans-10 dodecadienol (8,10-dddol)
STL562235
BS-49555
(e,e) -8,10-dodecadien-1-ol
8e, 10e-dodecadien-1-ol
codlemone ((e,e)-8,10-dddol, trans-8, trans-10-dodecadienol)
8e,10e-dodecadien-1-ol cas 33956-49-9
CS-0086580
(8z,10e)-dodecadien-1-ol

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"Field studies were conducted in the United States, Hungary, and New Zealand to evaluate the effectiveness of septa lures loaded with ethyl (E,Z)-2,4-decadienoate (pear ester) and (E)-4,8-dimethyl-1,3,7-nonatriene (nonatriene) alone and in combination with an acetic acid co-lure for both sexes of codling moth, Cydia pomonella (L."( A Binary Host Plant Volatile Lure Combined With Acetic Acid to Monitor Codling Moth (Lepidoptera: Tortricidae).
Basoalto, E; El-Sayed, AM; Katalin, J; Knight, AL, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" The dose-response relationships of males of susceptible and resistant strains to codlemone did not differ significantly."( Is attract-and-kill technology potent against insecticide-resistant Lepidoptera?
Beslay, D; Bouvier, JC; Poullot, D; Sauphanor, B, 2001
)
0.31
"1 mg codlemone lures so we caution that flight-tunnel experiments on preexposure may overestimate the actual pheromone exposure dosage received by feral moths in treated orchards."( Orientational behaviors and EAG responses of male codling moth after exposure to synthetic sex pheromone from various dispensers.
Gut, LJ; Miller, JR; Stelinski, LL, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
(8E,10E)-dodeca-8,10-dienol biosynthesis022

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
SMAD family member 2Homo sapiens (human)Potency54.94100.173734.304761.8120AID1346924
SMAD family member 3Homo sapiens (human)Potency54.94100.173734.304761.8120AID1346924
GLI family zinc finger 3Homo sapiens (human)Potency30.84110.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency63.17930.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743042; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency61.13060.000657.913322,387.1992AID1259378
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency38.89520.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency64.86010.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency31.71820.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency35.78090.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency61.13060.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency35.58850.000229.305416,493.5996AID743069; AID743075
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency54.94100.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency43.64120.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency36.75840.023723.228263.5986AID743222; AID743223; AID743241
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency61.13060.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency53.02830.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency57.80670.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.85)18.7374
1990's0 (0.00)18.2507
2000's9 (34.62)29.6817
2010's13 (50.00)24.3611
2020's3 (11.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.20 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index5.57 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]